
A genomics and policy researcher with the Li Ka Shing Knowledge Institute at St. Michael's Hospital in Toronto says the health and personal freedom of patients will be at risk if a challenge by the government of Quebec to Canada's year-old Genetic Non-Discrimination Act (GNA) is successful.
from CBC | Health News https://ift.tt/2IeVe0G
Aucun commentaire:
Enregistrer un commentaire